ALEXIS ELLIOTT: Open Payments
NPI 1720548753 · SILVERDALE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,940 in 108 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $144 · 2025 $1,940
Food & beverage: $1,788Education: $152
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $450 |
| Amgen Inc. | 14 | $422 |
| ABBVIE INC. | 24 | $273 |
| GENZYME CORPORATION | 6 | $192 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $154 |
| Novartis Pharmaceuticals Corporation | 17 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $91 |
| Galderma Laboratories, L.P. | 2 | $65 |
| UCB, Inc. | 3 | $56 |
| Arcutis Biotherapeutics, Inc. | 3 | $46 |
Products named: TREMFYA, OTEZLA, DUPIXENT, SKYRIZI, COSENTYX, RINVOQ, ILUMYA, Bimzelx.
Industry payments across WA — which companies pay providers there.
